Publications by authors named "Mustapha Alani"

Claim this Profile
S
Significant impact of immunosuppression on the incidence of secondary malignancies following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with indolent B-cell neoplasms.
Nathalie Denizon, Alix Baugier de Materre, Mustapha Alani, Habib Ghnaya, Jonathan Farhi

Leuk Lymphoma· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents.
Kamel Laribi, Mustapha Alani, Catherine Truong, Alix Baugier de Materre

Recent Pat Anticancer Drug Discov· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in the Treatment of Peripheral T-Cell Lymphoma.
Kamel Laribi, Mustapha Alani, Catherine Truong, Alix Baugier de Materre

Oncologist· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidine.
Kamel Laribi, Delphine Bolle, Mustapha Alani, Habib Ghnaya, Saga Le Bourdelles

Exp Hematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis